Viewing nowDongkwang Ibandronate Sodium Tablet 150 mg (Ibandronate Sodium Hydrate)
Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

MFDS item code 201306253 · Approved 2013.03.18 · Insurance code 645905420
Treatment of osteoporosis in postmenopausal women
This medicine is used for the treatment of osteoporosis, which commonly occurs in postmenopausal women. The decrease in female hormones due to menopause can lead to reduced bone density, and this medicine strengthens bones and reduces the risk of fractures. It is effective for the prevention of fractures caused by osteoporosis and maintaining bone health.
Take 1 tablet once a month on the same day each month in the morning, with plenty of water, at least 1 hour before consuming food, beverages (other than water), or any other oral medicines or dietary supplements (including calcium) : - This medicine must be swallowed with a sufficient amount of water (180-240ml) while standing or sitting upright, and you must not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine; therefore, take it with plain water. - To avoid esophageal ulcers, do not chew or suck the tablet. If a patient forgets to take a dose on the regularly scheduled dosing day - If 8 days or more remain until the next regularly scheduled dose, take 1 tablet the morning after realizing that a dose was missed, and thereafter take 1 tablet each month on the previously scheduled dosing day. - If 7 days or fewer remain until the next regularly scheduled dose, take 1 tablet on the next regularly scheduled dosing day, and thereafter continue taking 1 tablet each month on the previously scheduled dosing day. - Do not take 2 tablets in the same week. Patients whose dietary intake is inadequate should take supplements such as calcium or vitamin D. Patients with hepatic impairment No dosage adjustment is necessary Patients with renal impairment No dosage adjustment is necessary for patients with mild or moderate renal impairment with a creatinine clearance of 30mL/min or greater. Use of this medicine is not recommended in patients with a creatinine clearance of less than 30mL/min because clinical experience is insufficient. Older adults No dosage adjustment is necessary.
Efficacy and safety in children aged 18 years or younger have not been studied.
This medicine should not be used in certain patients. For example, individuals who are allergic to this medicine or its components, patients with low calcium levels in the blood, those who cannot sit upright or stand for more than 60 minutes, individuals with esophageal problems that hinder swallowing, and those with lactose intolerance or genetic lactose-related issues should not take this medicine. In patients with severe renal impairment, this medicine should be administered with caution. While taking this medicine, side effects such as dyspepsia, nausea, abdominal pain, diarrhea, headache, muscle pain, joint pain, and rash may occur. Some patients may experience influenza-like symptoms or gastrointestinal issues such as esophagitis and esophageal ulcers, so caution is needed. Additionally, if you experience difficulty swallowing, pain while swallowing, chest pain, or heartburn while taking this medicine, you should immediately stop taking it and consult a healthcare professional. Bisphosphonate drugs can cause serious side effects such as osteonecrosis of the jaws, so it is important to have a dental examination before using this medicine and to receive preventive treatment if necessary. Excessive dental treatments should be avoided during treatment, and if any abnormal symptoms occur in the jaw or around the ear, immediate consultation with a healthcare professional is required. This medicine may reduce its efficacy when taken with food, calcium supplements, antacids, etc., so it should not be taken with other foods or medications for at least 1 hour after administration. Pregnant or nursing women are advised not to use this medicine. Dose adjustment is not required for the elderly, but the safety and efficacy of this medicine in children under 18 years of age have not been established. In the case of overdose, gastrointestinal disturbances or hypocalcemia may occur, so it is essential to adhere to the correct dosage and consult a healthcare professional immediately if side effects arise. Lastly, this medicine should be kept out of the reach of children, and unused medication should be disposed of properly to prevent environmental pollution.
dyspepsia, nausea, abdominal pain, diarrhea, bloating, gastroesophageal reflux disease, headache, influenza-like illness, fatigue, muscle pain, joint pain, rash, gastritis, esophagitis, muscle cramps, musculoskeletal pain, musculoskeletal stiffness, dysphagia, vomiting, esophageal ulcer, stricture, dizziness, low back pain, duodenitis, hypersensitivity reaction, angioedema, facial swelling, urticaria, uveitis, scleritis, osteonecrosis of the jaw and external auditory canal, anaphylaxis, shock, exacerbation of asthma, Stevens-Johnson syndrome, erythema multiforme, vesicular dermatitis, atypical femoral fractures, atypical fractures of the iliac bone, visual disturbances, weakness, pruritus
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to protect it from air and moisture, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way can maintain the effectiveness of the medicine and prevent degradation.
White rectangular film-coated tablet
1 tablet [(1 tablet/PTP) × 1]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIbandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ibandronate Sodium Monohydrate 3.375mg
Solution · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.